SCHEMBL8673085

SCHEMBL8673085

CC(C)(C)C1CC(Oc2ccc(-n3ccc4cc(NC(=O)C5CC5)ccc43)nc2)CCN1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 2/20 0.46
GBA1 P04062 5/20 0.34
IDH1 O75874 1/20 0.34
ABL1 P00519 4/20 0.34
MAPT P10636 3/20 0.34
HTT P42858 2/20 0.33
ALDH1A1 P00352 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
USP2 O75604 1/20 0.33
DHODH Q02127 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
HPGD P15428 2/20 0.33
CSF1R P07333 1/20 0.33
FLT3 P36888 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8515181 0.90 CHRNA7 (0.40) CHRNA7MAPTALDH1A1DHODHMEN1
SCHEMBL8536654 0.89 CHRNA7 (0.39) CHRNA7MAPTDHODHCSF1RFLT3
SCHEMBL8532590 0.89 CHRNA7 (0.42) CHRNA7MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL8515709 0.86 ROCK1 (0.39) CHRNA7MAPTALDH1A1SMN1; SMN2HPGD
SCHEMBL15253110 0.85 GPR119 (0.38) CHRNA7
SCHEMBL15253249 0.85 SCN9A (0.38) MAPT
SCHEMBL8644871 0.84 CHRNA7 (0.36) CHRNA7MAPT
SCHEMBL15253213 0.84 GPR119 (0.36) CHRNA7LMNA
SCHEMBL8611402 0.84 GPR119 (0.33) CHRNA7
SCHEMBL15253268 0.84 MAPT (0.35) CHRNA7ABL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9000175-B2 Bicyclic GPR119 modulators LUPIN LIMITED (IN) 2015-04-07 US claimed
EP-2643311-A1 BICYCLIC GPR119 MODULATORS Lupin Limited (IN) 2013-10-02 EP claimed
US-20130245000-A1 BICYCLIC GPR119 MODULATORS LUPIN LIMITED (IN) 2013-09-19 US claimed
WO-2012069917-A1 BICYCLIC GPR119 MODULATORS LUPIN LIMITED (IN) 2012-05-31 WO claimed
US-9000175-B2 Bicyclic GPR119 modulators LUPIN LIMITED (IN) 2015-04-07 US disclosed
US-20130245000-A1 BICYCLIC GPR119 MODULATORS LUPIN LIMITED (IN) 2013-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130245000-A1 BICYCLIC GPR119 MODULATORS GPR119, GPR180, GPBAR1 CHRNA7 497/4885GBA1 655/4885IDH1 4130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.